NEW YORK (GenomeWeb) – LGC said today that it has acquired Lucigen, a developer, manufacturer, and supplier of molecular biology enzymes, reagents, and kits, for an undisclosed amount.

Founded in 1998, Lucigen currently employs over 65 people at its Middleton, Wisconsin site. It has an extensive portfolio of life science products including next-generation sequencing kits, enzymes, competent cells, and cloning systems, targeting fast growth applications in clinical diagnostics, drug discovery, synthetic biology, and gene editing.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.